The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

If tighter limits on mifepristone take effect, one immediate shift would be toward misoprostol-only protocols.

An at-home, mail-in, finger-stick blood test detected Alzheimer’s-related biomarkers associated with cognitive performance in ...

Labour turmoil threatens to overshadow NHS modernisation bill as Health Secretary Wes Streeting mulls leadership bid.

Two new studies have identified risk factors that may be associated with the increasing incidence of colorectal cancer among ...

Metabolic bariatric surgery use declined by 34.1% from 2022 through 2024, whereas GLP-1 prescriptions increased by more than ...

At an initial visit with a patient who is postpartum, clinicians should ask questions about pregnancy-related complications ...

Patients with mental illness seeking primary care show an elevated cardiovascular risk as per SCORE2, and targeted health ...

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

In a pooled analysis of the STEP trials, semaglutide produced substantial weight loss and cardiometabolic improvements in ...

Large language models performed better after full clinical data became available, raising concerns about early triage ...

Several newly identified biomarkers can help distinguish invasive aspergillosis from aspergillus colonization in lung transplant recipients, according to data from a new study presented at the annual ...